Proposed Criteria for Systematic Evaluation of Qualitative Oncology Research [0.03%]
定性肿瘤学研究系统评价标准的建议
Susan M Hannum,Sydney M Dy,Katherine C Smith et al.
Susan M Hannum et al.
Oncology has made significant advances in standardizing how clinical research is conducted and reported. The advancement of such research that improves oncology practice requires an expansion of not only our research questions but also the ...
Immune-Related Adverse Events Requiring Hospitalization: Spectrum of Toxicity, Treatment, and Outcomes [0.03%]
需要住院的免疫相关不良事件：毒性谱系、治疗及结果
Aanika Balaji,Jiajia Zhang,Beatriz Wills et al.
Aanika Balaji et al.
Purpose: Immune checkpoint inhibitors (ICIs) cause immune-related adverse events (irAEs). The proportion of patients who are hospitalized for irAEs and their spectrum, management, and outcomes are not well described. ...
Immune-Related Adverse Events Requiring Hospitalization: Spectrum of Toxicity, Treatment, and Outcomes [0.03%]
需要住院的免疫相关性不良事件：毒性谱系、治疗和预后
Aanika Balaji,Jiajia Zhang,Beatriz Wills et al.
Aanika Balaji et al.
Purpose: Immune checkpoint inhibitors (ICIs) cause immune-related adverse events (irAEs). The proportion of patients who are hospitalized for irAEs and their spectrum, management, and outcomes are not well described. ...
Determining If a Somatic Tumor Mutation Is Targetable and Options for Accessing Targeted Therapies [0.03%]
如何判断某个体系突变是否可以靶向以及怎样获取靶向药物
Suanna Steeby Bruinooge,Shimere Sherwood,Stephen Grubbs et al.
Suanna Steeby Bruinooge et al.
Targeted cancer therapies are drugs and biologics designed to affect cancer cell growth by blocking or interfering with specific molecular pathways in the cancer cell. Use of targeted agents usually requires verification through molecular t...
Determining If a Somatic Tumor Mutation Is Targetable and Options for Accessing Targeted Therapies [0.03%]
如何判断一个体细胞肿瘤突变是否可靶向以及获得靶向药物的途径
Suanna Steeby Bruinooge,Shimere Sherwood,Stephen Grubbs et al.
Suanna Steeby Bruinooge et al.
Targeted cancer therapies are drugs and biologics designed to affect cancer cell growth by blocking or interfering with specific molecular pathways in the cancer cell. Use of targeted agents usually requires verification through molecular t...
Next-Generation Sequencing in 305 Consecutive Patients: Clinical Outcomes and Management Changes [0.03%]
连续305例次下一代测序的临床结局及诊治变化
William Davis,Gabriel Makar,Pallav Mehta et al.
William Davis et al.
Purpose: Next-generation sequencing (NGS) is increasingly used to identify actionable mutations for oncology treatment. We examined the results and use of NGS assays at our institution. ...
Stephen A Bernard,Meredith D Keisler,John M Valgus et al.
Stephen A Bernard et al.
Esme Finlay,Kristina Newport,Mary Buss
Esme Finlay
Goals and Adverse Effects: Rate of Concordance Between Patients and Providers [0.03%]
患者与医生之间目标达成情况及不良反应报告的一致性分析
Katharine E Duckworth,Robert Morrell,Gregory B Russell et al.
Katharine E Duckworth et al.
Purpose: Adequate understanding of the goals and adverse effects of cancer treatment has important implications for patients' decision making, expectations, and mood. This study sought to identify the degree to which pati...
Rachel A Greenup,Christel Rushing,Laura Fish et al.
Rachel A Greenup et al.
Purpose: Financial toxicity is a well-recognized adverse effect of cancer care, yet little is known about how women consider treatment costs when facing preference-sensitive decisions for breast cancer surgery or how surg...